Delivery Order SPE2DB22D9367-SPE2DB25FSX65

Award Date 4/17/25
Potential Completion Date 5/8/25
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, with a ceiling value of $4,165.86 and an ultimate completion date of July 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $37,750.80, is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The delivery order was issued under an Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, with a total ceiling value of $3,418.70 and a period of performance through June 23, 2023. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product, with a ceiling value of $13,886.20. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. This award is part of a larger Indefinite Delivery Contract...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,734.96, is for the delivery of NEXPLANON 68 MG IMPLANTS to the DLA. This order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,146.90, is for the delivery of NEXPLANON 68 MG IMPLANTS and has an ultimate completion date of May 20, 2024. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,576.28, is for the delivery of NEXPLANON 68 MG IMPLANTS. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued up to $499,999,999, which allows the DLA to issue...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract has a ceiling value of $15,729.50 and covers the procurement of NEXPLANON 68 MG IMPLANTS, a prescription contraceptive device. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,550.16 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a specialized contraceptive product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to order a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $82,048.80, is for the delivery of 4562244975 NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military health facilities. This delivery order contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB25FSX65
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS and has a ceiling value of $6,943.10. The contract does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories.

Generated 7/17/25, 2:36 PM